Promoting the development of drugs against rare diseases: what more should be done?

Expert Rev Pharmacoecon Outcomes Res. 2012 Oct;12(5):541-3. doi: 10.1586/erp.12.56.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Drug Approval / legislation & jurisprudence
  • Drug Design*
  • European Union
  • Humans
  • Orphan Drug Production* / economics
  • Orphan Drug Production* / legislation & jurisprudence
  • Rare Diseases / drug therapy*
  • Research Support as Topic